Jeffrey Humphrey
CIK 1816944 · Chief Medical Officer · last filed 2024-06-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$948.6K
Companies
4
Total Filings
11
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNTH | Chief Medical Officer | 9,076 | $104.52 | $948.6K | $0 | 1 | 2024-06-20 |
| Cyteir Therapeutics, Inc. (CYT) Delisted | Director | — | $3.02 | — | $0 | 3 | 2023-02-07 |
| Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Chief Medical Officer | — | $11.19 | — | $0 | 4 | 2022-08-01 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Chief Medical Officer | — | $33.99 | — | $0 | 2 | 2021-02-18 |
Recent Filings · Page 2 of 2
11 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-07-08 | CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–11 of 11
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.